The future of personalized cancer treatment is on its way

BC Cancer Agency will launch innovative immunotherapy clinical trials beginning in 2017

Sponsored by BC Cancer Foundation | Impress Branded Content

After more than a decade of laboratory research, a revolutionary approach to cancer treatment is set to launch in British Columbia with clinical trials beginning early in the new year.

Dr. Brad Nelson, director of the BC Cancer Agency’s Deeley Research Centre in Victoria, and his colleagues are joining forces with experts at the BC Cancer Agency’s Genome Sciences Centre in Vancouver to deliver truly personalized immunotherapy to patients across the province.

Immunotherapy uses the body’s immune system to help combat cancer. T cells are the immune cells that circulate through the body searching for diseased cells to eliminate. In this case, the concept is to collect, activate, and expand a patient’s own cancer-fighting T cells and infuse large numbers of them back into the patient’s bloodstream.

Once in circulation, the T cells are expected to recognize and destroy cancer cells throughout the body, thereby “super charging” the patient’s immune response to their cancer.

The Deeley Research Centre is just one of three labs in Canada focusing on T cell immunotherapy, and is globally recognized for its work on ovarian cancer.

Thanks to the generous support of BC Cancer Foundation donors, the state-of-the-art Conconi Family Immunotherapy Lab at the BC Cancer Agency’s Deeley Research Centre will allow the research team to grow large numbers of potent, high quality T cells for re-infusion in patients participating in the upcoming clinical trials.

“T cell therapy is the most exciting development I have seen in my career, and research in this area has produced fantastic results,” says Dr. Nelson.

“Initial trials will focus on cervical, endometrial and ovarian cancer. With further support, we hope to extend our work to blood cancers, where genetic engineering will be used to give the T cells an extra boost in their power and precision.”

To help support the next round of trials for leukemia and lymphoma on Vancouver Island, please contact: Alyssa Grace, senior director, development – 250.519.5554 or 1.866.519.5550, or alyssa.grace@bccancer.bc.ca

To learn more about immunotherapy, please visit: bccancerfoundation.com/immunotherapy

Just Posted

VIDEO: Two people, dog escape house fire in Chilliwack

The early-morning blaze started around 6 a.m. on Third Avenue

Chilliwack Chiefs host Langley as Sardis Sports Complex opens

The BCHL teams will play a preseason game on the new ice sheet Aug. 29.

PHOTOS: Paintings return to Kilby for fifth annual festival

The Plein Air Festival will be taking place at the historic site all weekend

Envision Financial hosting barbecue fundraiser at Chilliwack’s Sardis Park to help fire victims

Residents of the Park Ridge apartment building are struggling in the wake of the devastating fire.

Cougar spotted in Seabird Island

Residents are asked to report all sightings to conservation

VIDEO: Find Me My Furever Home – Pekoe at the Chilliwack SPCA

Pekoe is a four-month-old male tabby at the Chilliwack SPCA who’s very playful and affectionate

U16 B.C. fastpitch team named national champs

Girls went undefeated at national tournament in Calgary

Advocates ‘internationalize’ the fight to free Raif Badawi from Saudi prison

Raif Badawi was arrested on June 17, 2012, and was later sentenced to 1,000 lashes and 10 years in jail for his online criticism of Saudi clerics

Canadian entrepreneurs turning beer byproduct into bread, cookies and profits

Some breweries turn to entrepreneurs looking to turn spent grain into treats for people and their pets

Canada ‘disappointed’ terror suspect’s British citizenship revoked

Jack Letts, who was dubbed “Jihadi Jack” by the U.K. media, has been detained in a Kurdish prison for about two years

Chrystia Freeland condemns violence in Hong Kong, backs right to peaceful assembly

There have been months of protests in the semi-autonomous region

Most Read